Page last updated: 2024-12-05

n,n-dimethylbenzamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

N,N-dimethylbenzamide (DMBA) is a synthetic compound with a wide range of applications. It is commonly used as a solvent, a reagent in organic synthesis, and a precursor to other chemicals. DMBA is synthesized through the reaction of benzoyl chloride with dimethylamine. Its unique chemical properties make it an important building block in the production of pharmaceuticals, agrochemicals, and polymers. DMBA is also studied for its potential biological effects, including its ability to inhibit the growth of certain cancer cells. Its research interest stems from its structural similarity to naturally occurring molecules and its potential applications in medicinal chemistry.'

Cross-References

ID SourceID
PubMed CID11916
CHEMBL ID453210
SCHEMBL ID30062
MeSH IDM0115903

Synonyms (39)

Synonym
einecs 210-279-2
ai3-01462
nsc 10996
nsc-10996
611-74-5
nsc10996
wln: 1n1&vr
dimethylbenzamide
dimethylbenzmide
n,n-dimethylbenzamide
inchi=1/c9h11no/c1-10(2)9(11)8-6-4-3-5-7-8/h3-7h,1-2h
benzamide, n,n-dimethyl-
n,n-dimethylbenzamide, 99%
nn-dimethylbenzamide
D0256
CHEMBL453210
AKOS003557033
n,n-dimethyl-benzamide
unii-mx2vx9mh4t
mx2vx9mh4t ,
FT-0629523
SCHEMBL30062
n,n-dimethyl benzamide
dmbz
DTXSID4060602
mfcd00008320
STL481803
J-523269
n,n-dmethylbenzamde
n,n-dimetyl-benzamide
Q63408886
FS-4461
D70353
n-dimethylbenzamide
SY048849
A868789
EN300-6767796
CS-W018175
Z32014402

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" The project team was able to improve the bioavailability by reducing efflux through systematic modifications to the strength of the HBA by changing the electronic properties of neighboring groups, whilst maintaining sufficient acceptor strength for potency."( Modulating the strength of hydrogen bond acceptors to achieve low Caco2 efflux for oral bioavailability of PARP inhibitors blocking centrosome clustering.
Eisman, MS; Gu, C; Harrison, RA; Hu, H; Johannes, JW; Kazmirski, S; Lamb, ML; Lyne, PD; Mikule, K; Peng, B; Scott, DA; Su, N; Sylvester, MA; Wang, W; Ye, Q; Zheng, X, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID343398Octanol-water distribution coefficient, log D at pH 7.4 by shake-flask technique2008Journal of medicinal chemistry, Jul-10, Volume: 51, Issue:13
Toward prediction of alkane/water partition coefficients.
AID1321514Dissociation constant, pKa of the compound2016Bioorganic & medicinal chemistry letters, 10-01, Volume: 26, Issue:19
Modulating the strength of hydrogen bond acceptors to achieve low Caco2 efflux for oral bioavailability of PARP inhibitors blocking centrosome clustering.
AID1134601Hydrogen-bond basicity, pKHB of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID1134599CHCl3-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID343680Hexadecane-water distribution coefficient, log D at pH 7.4 by shake-flask technique2008Journal of medicinal chemistry, Jul-10, Volume: 51, Issue:13
Toward prediction of alkane/water partition coefficients.
AID1134600Octanol-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's1 (14.29)18.2507
2000's1 (14.29)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.18

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.18 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.18)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]